Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
Front Physiol ; 15: 1459031, 2024.
Article in English | MEDLINE | ID: mdl-39282085

ABSTRACT

Introduction: The trend of human migration to terrestrial high altitudes (HA) has been increasing over the years. However, no published prospective studies exist with follow-up periods exceeding 1 month to investigate the cardiac change. This prospective study aimed to investigate the changes in cardiac structure and function in healthy young male lowlanders following long-term migration to HA. Methods: A total of 122 Chinese healthy young males were divided into 2 groups: those migrating to altitudes between 3600 m and 4000 m (low HA group, n = 65) and those migrating to altitudes between 4000 m and 4700 m (high HA group, n = 57). Traditional echocardiographic parameters were measured at sea level, 1 month and 1 year after migration to HA. Results: All 4 cardiac chamber dimensions, areas, and volumes decreased after both 1 month and 1 year of HA exposure. This reduction was more pronounced in the high HA group than in the low HA group. Bi-ventricular diastolic function decreased after 1 month of HA exposure, while systolic function decreased after 1 year. Notably, these functional changes were not significantly influenced by altitude differences. Dilation of the pulmonary artery and a progressive increase in pulmonary artery systolic pressure were observed with both increasing exposure time and altitude. Additionally, a decreased diameter of the inferior vena cava and reduced bicuspid and tricuspid blood flow velocity indicated reduced blood flow following migration to the HA. Discussion: 1 year of migration to HA is associated with decreased blood volume and enhanced hypoxic pulmonary vasoconstriction. These factors contribute to reduced cardiac chamber size and slight declines in bi-ventricular function.

2.
Langmuir ; 40(36): 19209-19219, 2024 Sep 10.
Article in English | MEDLINE | ID: mdl-39208147

ABSTRACT

Spontaneous imbibition is a naturally occurring phenomenon in porous media that plays an important role in various processes. Particularly during the oil recovery process, imbibition efficiency could be significantly affected by the physical properties of the reservoir rock, such as pore-throat structure. However, the effect of the pore-throat structure on the imbibition process has rarely been investigated quantitatively. Therefore, in this study, spontaneous imbibition was examined quantitatively using microfluidic devices with different single pore-throat geometries. Three key geometric parameters were examined, namely, pore-throat ratio, coordination number, and tortuosity. The pore-to-throat ratio of a single pore-to-throat structure under investigation ranges from 3 to 50. Designated coordination numbers range from 2 to 6. Tortuosity values for meandering channels range from 1 to 2. Imbibition process was mimicked using microfluidic devices with varying pore-throat geometries. The results showed that average imbibition velocity exhibited an initial increase followed by a subsequent decline with the increase in the pore-throat ratio. As the coordination number increased, imbibition velocity decreased as the coordination number increased, and the influence of the pore-throat ratio diminished as the coordination number increased. Imbibition velocity decreased as the tortuosity increased. Meniscus movements were investigated for different pore-throat structures. Statistical analysis was also conducted to determine the dominant factor governing the imbibition behavior. It was found that pore-throat ratio, tortuosity, and coordination number exerted a decreasing impact on the imbibition velocity. Wetting phase saturation was examined over time using a single pore-throat geometry device with varying pore-throat ratios. Four distinct types of imbibition behaviors were identified and characterized. In conclusion, this work examined the imbibition behaviors within specified pore-throat geometries, which could contribute to a comprehensive understanding of the imbibition behavior in realistic porous media.

3.
BMC Endocr Disord ; 24(1): 166, 2024 Aug 30.
Article in English | MEDLINE | ID: mdl-39215269

ABSTRACT

OBJECTIVE: This Study aims to investigate the risk factors of hypoglycemia in neonates through meta-analysis. METHOD: PubMed, Embase, Cochrane library, and Web of science databases were searched for case-control studies on risk factors for neonatal hypoglycemia. The search was done up to 1st October 2023 and Stata 15.0 was used for data analysis. RESULTS: A total of 12 published studies were included, including 991 neonates in the hypoglycemic group and 4388 neonates in the non-hypoglycemic group. Meta-analysis results suggested caesarean section [OR = 1.90 95%CI (1.23, 2.92)], small gestational age[OR = 2.88, 95%CI (1.59, 5.20)], gestational diabetes [OR = 1.65, 95%CI (1.11, 2.46)], gestational hypertension[OR = 2,79, 95%CI (1.78, 4.35)] and respiratory distress syndrome[OR = 5.33, 95%CI (2.22, 12.84)] were risk factors for neonatal hypoglycemia. CONCLUSION: Based on the current study, we found that caesarean section, small gestational age, gestational diabetes, gestational hypertension, respiratory distress syndrome are risk factors for neonatal hypoglycemia. PROSPERO REGISTRATION NUMBER: CRD42023472974.


Subject(s)
Diabetes, Gestational , Hypoglycemia , Humans , Hypoglycemia/epidemiology , Infant, Newborn , Risk Factors , Female , Pregnancy , Diabetes, Gestational/epidemiology , Cesarean Section/statistics & numerical data , Infant, Newborn, Diseases/epidemiology , Infant, Newborn, Diseases/etiology , Hypertension, Pregnancy-Induced/epidemiology , Respiratory Distress Syndrome, Newborn/epidemiology , Respiratory Distress Syndrome, Newborn/etiology , Case-Control Studies
4.
Health Psychol ; 2024 Aug 15.
Article in English | MEDLINE | ID: mdl-39146068

ABSTRACT

OBJECTIVE: Despite the recognized importance of posttraumatic growth (PTG) in the recovery process, the mechanisms that promote PTG in spinal cord injury (SCI) patients and their spouses, especially the roles of dyadic coping (DC) and resilience, have not been fully explored. This study aimed to assess the PTG of patients with SCI and their spouses and to investigate the interrelationships among DC, resilience, and PTG within the dyadic context. METHOD: A total of 154 SCI patient-spouse dyads were recruited from a rehabilitation hospital in China. All participants completed questionnaires about DC, resilience, and PTG. Our study was based on the actor-partner interdependence mediation model (APIMeM). RESULTS: SCI patients and their spouses experienced comparable PTG level, M(patients) = 56.05 ± 14.09, M(spouses) = 54.74 ± 15.31. In the APIMeM, the patients' and their spouses' DC exerted actor effects on their own resilience, ß(patients) = .418, p < .001; ß(spouses) = .409, p < .01, and their own resilience also exerted actor effects on their own PTG, ß(patients) = .416, p < .001; ß(spouses) = .431, p < .001. The mediating effects of resilience on the impact of patients' and spouses' own DC on their own PTG were confirmed. CONCLUSIONS: Our research offers new insight into the PTG of SCI patients and their spouses at the individual and dyadic levels. Resilience partially mediates the relationship between DC and PTG in couples coping with SCI. Specifically, DC between SCI patient-spouse dyads can not only directly influence the level of PTG but also impact PTG through resilience. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

5.
J Clin Ultrasound ; 2024 May 24.
Article in English | MEDLINE | ID: mdl-38786768

ABSTRACT

Liver involvement in lymphoma often manifests as nonoccupying diffuse infiltration, posing challenges in distinguishing it from primary liver disorder. Herein, we present the case of a 21-year-old female who underwent two separate diagnoses within a nine-month interval before being ultimately diagnosed with peripheral T-cell lymphoma, not otherwise specified. Our review of this case identified an ultrasound imaging feature, the hypoechoic periportal cuffing. When combined with associated increased lymphocyte count and liver enlargement, it can serve as a noninvasive suggestion for malignant disorders, in particular hemic and lymphatic diseases.

6.
Ann Hematol ; 103(9): 3627-3637, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38647678

ABSTRACT

Iron contributes to tumor initiation and progression; however, excessive intracellular free Fe2+ can be toxic to cancer cells. Our findings confirmed that multiple myeloma (MM) cells exhibited elevated intracellular iron levels and increased ferritin, a key protein for iron storage, compared with normal cells. Interestingly, Bortezomib (BTZ) was found to trigger ferritin degradation, increase free intracellular Fe2+, and promote ferroptosis in MM cells. Subsequent mechanistic investigation revealed that BTZ effectively increased NCOA4 levels by preventing proteasomal degradation in MM cells. When we knocked down NCOA4 or blocked autophagy using chloroquine, BTZ-induced ferritin degradation and the increase in intracellular free Fe2+ were significantly reduced in MM cells, confirming the role of BTZ in enhancing ferritinophagy. Furthermore, the combination of BTZ with RSL-3, a specific inhibitor of GPX4 and inducer of ferroptosis, synergistically promoted ferroptosis in MM cell lines and increased cell death in both MM cell lines and primary MM cells. The induction of ferroptosis inhibitor liproxstatin-1 successfully counteracted the synergistic effect of BTZ and RSL-3 in MM cells. Altogether, our findings reveal that BTZ elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 by increasing ferroptosisin MM cells.


Subject(s)
Bortezomib , Drug Synergism , Ferritins , Ferroptosis , Iron , Multiple Myeloma , Nuclear Receptor Coactivators , Humans , Multiple Myeloma/metabolism , Multiple Myeloma/drug therapy , Multiple Myeloma/pathology , Nuclear Receptor Coactivators/metabolism , Nuclear Receptor Coactivators/genetics , Bortezomib/pharmacology , Ferritins/metabolism , Ferroptosis/drug effects , Iron/metabolism , Cell Line, Tumor , Autophagy/drug effects , Antineoplastic Agents/pharmacology , Carbolines
7.
Ann Hematol ; 103(4): 1293-1303, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38148345

ABSTRACT

Diallyl disulfide (DADS), one of the main components of garlic, is well known to have anticancer effects on multiple cancers. However, its efficacy in treating multiple myeloma (MM) is yet to be determined. We explored the effects of DADS on MM cells and investigated the synergistic effects of DADS when combined with five anti-MM drugs, including melphalan, bortezomib, carfilzomib, doxorubicin, and lenalidomide. We analyzed cell viability, cell apoptosis, and DNA damage to determine the efficacy of DADS and the drug combinations. Our findings revealed that DADS induces apoptosis in MM cells through the mitochondria-dependent pathway and increases the levels of γ-H2AX, a DNA damage marker. Combination index (CI) measurements indicated that the combination of DADS with melphalan has a significant synergistic effect on MM cells. This was further confirmed by the increases in apoptotic cells and DNA damage in MM cells treated with the two drug combinations compared with those cells treated with a single drug alone. The synergy between DADS and melphalan was also observed in primary MM cells. Furthermore, mechanistic investigations showed that DADS decreases reduced glutathione (GSH) levels and increases reactive oxygen species (ROS) production in MM cells. The addition of GSH is effective in neutralizing DADS cytotoxicity and inhibiting the synergy between DADS and melphalan in MM cells. Taken together, our study highlights the effectiveness of DADS in treating MM cells and the promising therapeutic potential of combining DADS and melphalan for MM treatment.


Subject(s)
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid/analogs & derivatives , Allyl Compounds , Disulfides , Melphalan , Multiple Myeloma , Humans , Reactive Oxygen Species , Melphalan/pharmacology , Multiple Myeloma/drug therapy , DNA Damage , Apoptosis , Drug Combinations
8.
Curr Eye Res ; 48(7): 674-682, 2023 07.
Article in English | MEDLINE | ID: mdl-37025011

ABSTRACT

PURPOSE: To explore whether melanopsin is associated with the development of myopia. METHODS: Seventy-two guinea pigs (3 weeks older) were randomly assigned to 6 groups: the form-deprivation myopia (FDM) group (monocularly covering the right eye for 14 days, n = 15), the FDM recovery group (removing the eye mask for 3 days, n = 13), the lens-induced myopia (LIM) group (monocularly wearing a -4D lens for 3 days, n = 15), the LIM recovery group (removing the lens for 2 days, n = 13), and another 2 age-matched normal groups (n = 8 each). The diopter, the vitreous chamber depth (VCD), and the axial length (AXL) were measured to confirm the effect of the treatments. Immunofluorescence and western blotting methods were used to examine the expression of melanopsin in the retina. RESULTS: Immunofluorescent results showed that in the FDM group, the melanopsin intensity in the retina of experimental eyes significantly decreased compared to those of contralateral eyes, but no significant difference was observed during their recovery periods. Western blotting showed that the expression of melanopsin in the experimental eyes of the FDM group was lower than that of the contralateral eyes (fold: 1.00 versus 1.36). The expression of melanopsin in the experimental eyes increased 3 days after removing form deprivation, although a slight reduction in melanopsin expression compared to that of the contralateral eyes (fold: 1.41 versus 1.58). For the LIM group, immunofluorescent showed an obvious decreased intensity of melanopsin-labeled cells in the experimental eyes compared to the contralateral eyes. Western blotting showed that although melanopsin expression in the experimental eyes decreased compared to that of the contralateral eyes (fold: 1.00 versus 1.96), no differences were found between two eyes 2 days after lens removal (fold: 1.99 versus 2.00). CONCLUSION: The decreased expression of melanopsin in the retina may potentially participate in the development of FDM and LIM.


Subject(s)
Lens, Crystalline , Myopia , Guinea Pigs , Animals , Disease Models, Animal , Myopia/metabolism , Retina/metabolism , Lens, Crystalline/metabolism
9.
J Plast Reconstr Aesthet Surg ; 77: 309-318, 2023 02.
Article in English | MEDLINE | ID: mdl-36610276

ABSTRACT

The dorsal metacarpal artery flap (DMAF) is irrefutable as an effective way of repairing long finger defects, and hand surgeons might consider using it for long finger reconstruction or degloved injury repair. Unfortunately, the DMAF containing a single dorsal metacarpal artery (DMA) hinders the treatment effect. The sensory restoration of long fingers and the reconstruction of phalangeal joints and tendon grafts are unsolved challenges as well. We reported our experience in reconstructing the index and middle finger by a reverse-island flap with two DMAs and dorsal metacarpal nerves (DMNs) with blood supply. We reviewed ten patients with finger-crush injuries affecting eight index fingers and two middle fingers. Degloving injuries occurred in two patients, and finger amputations occurred in eight others. Two patients received simple flap reconstruction, and eight received finger reconstruction, including seven from abandoned phalangeal joints and tendon grafts of the severed finger and one from the iliac crest bone graft. All patients underwent finger reconstruction by an expanded reverse-island flap consisting of two DMAs and DMNs up to a maximal size of 9 × 8 cm2. Postoperative follow-up evaluation showed a satisfactory appearance and functional recovery of the reconstructed fingers. We posit that the expanded reverse-island flap involving two DMAs and DMNs constitutes a feasible and safe option for restoring a severely damaged index or middle finger, particularly for patients who are unwilling to undergo toe-to-finger transplantation to reconstruct the injured long fingers.


Subject(s)
Degloving Injuries , Finger Injuries , Metacarpal Bones , Plastic Surgery Procedures , Soft Tissue Injuries , Humans , Amputation, Surgical , Arteries/surgery , Degloving Injuries/surgery , Finger Injuries/surgery , Fingers/blood supply , Metacarpal Bones/surgery , Skin Transplantation , Soft Tissue Injuries/surgery , Surgical Flaps/blood supply , Treatment Outcome
10.
Environ Toxicol ; 38(4): 950-961, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36715115

ABSTRACT

OBJECTIVE: We assessed the function and mechanism of RNA binding motif protein 15 (RBM15) silencing in lung cancer development. METHODS: The effects of RBM15 knockdown on A549 and H1299 cells were evaluated by MTT, EdU, wound healing, and transwell assay. We then detected the functions of RBM15 silencing on lipid peroxidation, labile iron pool (LIP), ferrous iron (Fe2+ ), and ferroptosis-related genes. RNA sequencing was performed after RBM15 knockout in lung cancer cells, followed by differentially expressed genes (DEGs), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed. Finally, the expression of RBM15 and pathway-related genes was determined by western blot. RESULTS: RBM15 was highly expressed in lung cancer cells. RBM15 silencing reduced the viability, inhibited cell proliferation, invasion, and migration, and suppressed tumor growth in the xenograft mouse model. Knockout of RBM15 regulated ferroptosis-related gene expression. LIP, Fe2+ , and lipid peroxidation were distinctly increased by the knockout of RBM15. RNA-seq sequencing revealed that there are 367 up-regulated and 368 down-regulated DEGs, which were enriched in molecular functions, biological processes, and cellular components. RBM15 silencing reduced the expression of TGF-ß/Smad2, and TGF-ß activator (SRI-011381) reversed the inhibitory effect of RBM15 silencing on tumor cell growth. CONCLUSION: We demonstrated that RBM15 silencing promoted ferroptosis in lung cancer cells by TGF-ß/Smad2 pathway, thereby inhibiting lung cancer cell growth, which may provide new light for lung cancer treatment.


Subject(s)
Ferroptosis , Lung Neoplasms , Humans , Animals , Mice , Transforming Growth Factor beta/metabolism , Mice, Knockout , Lung Neoplasms/genetics , Cell Proliferation , Cell Line, Tumor , RNA-Binding Proteins , Smad2 Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL